One third of hepatitis B carriers in Hong Kong have severe liver fibrosisBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39556.489097.DB (Published 24 April 2008) Cite this as: BMJ 2008;336:909
- Jane Parry
- 1Hong Kong
Researchers in Hong Kong have found that one third of people in the city who are hepatitis B carriers have severe fibrosis, including almost a fifth of patients with normal alanine transferase (ALT) concentrations. The findings of a study of 1315 hepatitis B carriers were published in the American Journal of Gastroenterology (2008 Apr 16; doi: 10.1111/j.1572-0241.2007.01751.x).
“It’s known that severe fibrosis and cirrhosis can lead to complications, including liver cancer, but we didn’t know the extent of the problem of severe fibrosis,” said Man-fung Yuen, coauthor of the study and associate professor at the University of Hong Kong’s department of medicine.